The following temporary anatomical therapeutic chemical (ATC) classifications and defined daily doses (DDDs) were agreed at a meeting of the WHO International Working Group for Drug Statistics Methodology which took place on 23 and 24 March 2000. Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology, e-mail: whocc@nmd.no, before 1 August 2000. If no objections are received before this date, the new ATC codes and DDDs will be considered final and will be included in the January 2001 issue of the ATC index. The inclusion of a substance in the lists does not imply any recommendation of use in medicine or pharmacy. |
ATC level |
INN/common name |
ATC code |
New ATC level codes (other than 5th level): |
Vasopeptidase inhibitors, plain |
|
C09E |
Vasopeptidase Inhibitors, plain |
|
C09EA |
Drugs used in alcohol dependence |
|
N07BB |
Drugs used in opioid dependence |
|
N07BC |
Change of level name: |
Previous: Antismoking agents New: Drugs used in addictive disorders |
|
N07B |
Previous: Antismoking agents New: Drugs used in nicotine dependence |
|
N07BA |
Previous: Oxytocin and derivatives New: Oxytocin and analogues |
|
H01BB |
New ATC 5th level codes: |
|
almotriptan |
N02CC05 |
|
buprenorphine |
N07BC01 |
|
carbetocin |
H01BB03 |
|
dihydroemetine |
P01AX09 |
|
diosmectite |
A07BC05 |
|
esomeprazole |
A02BC05 |
|
exemestane |
L02BG06 |
|
gatifloxacin |
J01MA16 |
|
gemifloxacin |
J01MA15 |
|
glucose, combinations |
C05BB56 |
|
hydroquinone |
D11AX11 |
|
inositol |
A11HA07 |
|
isotretinoin, combinations |
D10AD54 |
|
leflunomide |
L04AA13 |
|
macrogol |
A06AD15 |
|
melanoma vaccine |
L03AX12 |
|
nateglinide |
A10BX03 |
|
nitisinone |
A16AX04 |
|
octenidine, combinations |
D08AJ57 |
|
octenidine, combinations |
G01AX16 |
|
omapatrilat |
C09EA01 |
|
propanofen |
S01BC09 |
|
risedronic acid |
M05BA07 |
|
sodium fluoride, combinations |
A01AA51 |
|
technetium (99mTc) sulesomab |
V09HA04 |
|
thiamphenicol, combinations |
J01BA52 |
|
verteporfin |
L01XX26 |
ATC code changes: |
|
acamprosate |
V03AA03 |
N07BB03 |
|
calcium carbimide |
V03AA02 |
N07BB02 |
|
disulfiram |
V03AA01 |
N07BB01 |
|
levacetylmethadol |
N02AC06 |
N07BC03 |
|
methadone |
N02AC02 |
N07BC02 |
|
naltrexone |
V03AB30 |
N07BB04 |
New DDDs:
INN/common name |
DDD |
Unit |
Route of Administration |
ATC code |
amodiaquine |
0.5 |
g |
O |
P01BA06 |
artemether |
0.28 |
g |
O |
P01BE02 |
artemisinin |
1 |
g |
O |
P01BE01 |
artenimol** |
0.28 |
g |
O |
P01BE05 |
artesunate |
0.28 |
g |
O |
P01BE03 |
dihydroemetine |
60 |
mg |
P |
P01AX09* |
exemestane |
25 |
mg |
O |
L02BG06* |
galantamine |
24 |
mg |
O |
N06DA04 |
halofantrine |
1.5 |
g |
O |
P01BX01 |
ibandronic acid |
4 |
mg |
P*** |
M05BA06 |
leflunomide |
15 |
mg |
O |
L04AA13* |
macrogol**** |
10 |
g |
O |
A06AD15* |
mercaptamine |
2 |
g |
O |
A16AA04 |
pioglitazone |
30 |
mg |
O |
A10BG03 |
risedronic acid |
30 |
mg |
O |
M05BA07* |
tirofiban |
10 |
mg |
P |
B01AC17 |
troglitazone |
0.4 |
g |
O |
A10BG01 |
valproic acid |
1.5 |
g |
R |
N03AG01 |
zotepine |
0.2 |
g |
O |
N05AX11 |
* Temporary ATC code
** Previously: dihydroartemisinin
*** Course dose
*** Refers to macrogol 4000